Universe Pharmaceuticals (UPC) Current Taxes (2020 - 2025)

Universe Pharmaceuticals has disclosed Current Taxes across 6 years of filings, most recently posting $640.8 million for Q3 2025.

• Current Taxes for Q3 2025 came in at $640.8 million, down 37.25% year-over-year; the trailing twelve-month figure through Sep 2025 was $640.8 million (down 37.25% YoY), and the FY2025 annual result was $640.8 million, down 37.25% from the prior year.
• Current Taxes came in at $640.8 million for Q3 2025 at Universe Pharmaceuticals, down from $1.0 billion in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $1.0 billion in Q3 2024 to a low of $434758.0 in Q3 2023.
• The 5-year median for Current Taxes is $1.5 million (2021), against an average of $332.9 million.
• Across the five-year window, Current Taxes plunged 54.25% in 2022 and jumped 234784.92% in 2024, its largest moves.
• Universe Pharmaceuticals' Current Taxes stood at $1.5 million in 2021, then slumped by 54.25% to $694955.0 in 2022, then slumped by 37.44% to $434758.0 in 2023, then surged by 234784.92% to $1.0 billion in 2024, then tumbled by 37.25% to $640.8 million in 2025.
• The last three Current Taxes figures came in at $640.8 million (Q3 2025), $1.0 billion (Q3 2024), and $434758.0 (Q3 2023), per Business Quant data.